Fil LTD Ascendis Pharma A/S Transaction History

Fil LTD

$96.6 Billion
Q1 2025

A detailed history of Fil LTD transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Fil LTD holds 462,366 shares of ASND stock, worth $72.7 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

462,366

Previous 729,275 36.6%

Holding current value

$72.7 Million

Previous $100 Million 28.22%

% of portfolio

0.07%

Previous 0.1%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	SELL	$119.49 - $168.84 $31.9 Million - $45.1 Million	-266,909 Reduced 36.6%	462,366 $72.1 Million
Q4 2024 Feb 13, 2025	BUY	$122.0 - $146.6 $10.9 Million - $13 Million	89,016 Added 13.9%	729,275 $100 Million
Q3 2024 Nov 13, 2024	BUY	$113.0 - $153.43 $22.3 Million - $30.3 Million	197,751 Added 44.69%	640,259 $95.6 Million
Q2 2024 Aug 13, 2024	BUY	$121.07 - $153.67 $52.3 Million - $66.4 Million	431,781 Added 4025.18%	442,508 $60.3 Million
Q1 2024 May 13, 2024	BUY	$123.45 - $159.4 $583,795 - $753,802	4,729 Added 78.84%	10,727 $1.62 Million
Q4 2023 Feb 13, 2024	BUY	$86.1 - $127.36 $516,427 - $763,905	5,998 New	5,998 $755,000
Q1 2023 May 11, 2023	SELL	$104.9 - $126.78 $6,818 - $8,240	-65 Reduced 0.14%	45,000 $4.82 Million
Q4 2022 Feb 13, 2023	BUY	$99.42 - $131.97 $4.48 Million - $5.95 Million	45,065 New	45,065 $5.5 Million
Q4 2021 Feb 14, 2022	SELL	$127.1 - $169.66 $85,029 - $113,502	-669 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$112.67 - $176.92 $15.1 Million - $23.8 Million	-134,325 Reduced 99.5%	669 $107,000
Q2 2021 Aug 13, 2021	SELL	$121.62 - $145.29 $4.49 Million - $5.36 Million	-36,889 Reduced 21.46%	134,994 $17.8 Million
Q1 2021 May 14, 2021	BUY	$124.92 - $173.33 $1.04 Million - $1.45 Million	8,359 Added 5.11%	171,883 $22.2 Million
Q4 2020 Feb 08, 2021	BUY	$151.2 - $182.76 $10.4 Million - $12.5 Million	68,607 Added 72.28%	163,524 $27.3 Million
Q3 2020 Nov 13, 2020	BUY	$134.29 - $154.32 $16,651 - $19,135	124 Added 0.13%	94,917 $14.6 Million
Q2 2020 Aug 13, 2020	SELL	$110.87 - $156.01 $10.8 Million - $15.2 Million	-97,171 Reduced 50.62%	94,793 $14 Million
Q1 2020 May 14, 2020	BUY	$97.01 - $145.11 $2.17 Million - $3.24 Million	22,328 Added 13.16%	191,964 $21.6 Million
Q4 2019 Feb 07, 2020	SELL	$91.45 - $139.12 $1.37 Million - $2.08 Million	-14,967 Reduced 8.11%	169,636 $23.6 Million
Q3 2019 Nov 13, 2019	SELL	$95.8 - $118.9 $2.83 Million - $3.52 Million	-29,575 Reduced 13.81%	184,603 $17.7 Million
Q2 2019 Aug 13, 2019	SELL	$107.11 - $132.09 $3.7 Million - $4.56 Million	-34,521 Reduced 13.88%	214,178 $24.7 Million
Q1 2019 May 13, 2019	BUY	$62.15 - $129.99 $7.58 Million - $15.8 Million	121,912 Added 96.15%	248,699 $29.3 Million
Q4 2018 Feb 13, 2019	BUY	$55.16 - $69.67 $753,982 - $952,319	13,669 Added 12.08%	126,787 $7.94 Million
Q3 2018 Nov 09, 2018	BUY	$63.77 - $76.28 $5 Million - $5.99 Million	78,474 Added 226.52%	113,118 $8.02 Million
Q2 2018 Aug 10, 2018	BUY	$58.55 - $73.92 $2.03 Million - $2.56 Million	34,644 New	34,644 $2.31 Million

Others Institutions Holding ASND

# of Institutions

270

Shares Held

61.9M

Call Options Held

151K

Put Options Held

226K

View Full List

About Ascendis Pharma A/S

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $8.78B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

More about ASND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fil LTD, based on Form 13F filings with the SEC.

News

Stay updated on Fil LTD with notifications on news.

Account